Prospective surveillance of women with a family history of breast cancer: Auditing the risk threshold

British Journal of Cancer

Volumn 98, Issue 4, 2008, Pages 840-844

  Anderson, E ^a   Berg, J ^b   Black, R ^c   Bradshaw, N ^d   Campbell, J ^a   Carnaghan, H ^e   Cetnarkyj, R ^a   Drummond, S ^a   Davidson, R ^d   Dunlop, J ^b   Fordyce, A ^c   Gibbons, B ^f   Goudie, D ^b   Gregory, H ^f   Holloway, S ^a   Longmuir, M ^d   McLeish, L ^b   Murday, V ^d   Miedzybrodska, Z ^f   Nicholson, D ^c   Pearson, P ^a   Porteous, M ^a   Reis, M ^b   Slater, S ^a   Smith, K ^c   Smyth, E ^c   Snadden, L ^d   Steel, M ^e   Stirling, D ^a   Watt, C ^d   Whyte, C ^a   Young, D ^b   more..

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

^b NINEWELLS HOSPITAL   (United Kingdom)

^c HEALTHCARE IMPROVEMENT SCOTLAND   (United Kingdom)

^d Ferguson Smith Centre for Clinical Genetics   (United Kingdom)

^e UNIVERSITY OF ST ANDREWS   (United Kingdom)

^f ABERDEEN ROYAL INFIRMARY   (United Kingdom)

Author keywords

Breast cancer; Familial; Risk assessment

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER RISK; CANCER SCREENING; FAMILY HISTORY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; UNITED KINGDOM;

ADENOCARCINOMA; ADULT; AGE DISTRIBUTION; AGED; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; GUIDELINES AS TOPIC; HUMANS; INCIDENCE; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; NEOPLASM INVASIVENESS; POPULATION SURVEILLANCE; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SCOTLAND;

EID: 39449125555     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6604155     Document Type: Article

References (14)

1. Amir A, Evans DG, Shenton A, Lalloo F, Moran A, Boggis C, Wilson M, Howell A (2003) Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme. J Med Genet 40: 807-814
2. Breakthrough Breast Cancer (2004) Breast cancer risk factors; the facts. London
3. Claus EB, Risch N, Thompson WD (1991) Genetic analysis of breast cancer in the cancer and steroid hormone study. Am J Hum Genet 48: 232-242
4. Collaborative Group on Hormonal Factors in Breast Cancer (2001) Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58209 women with breast cancer and 101 986 women without the disease. Lancet 358: 1389-1399
5. Easton DF, Pooley KA, Dunning AM, Pharoah PD, Thompson D, Ballinger DG, Struewing JP, Morrison J, Field H, Luben R, Wareham N, Ahmed S, Healey CS, Bowman R, SEARCH collaborators, Meyer KB, Haiman CA, Kolonel LK, Henderson BE, Le Marchand L, Brennan P, Sangrajrang S, Gaborieau V, Odefrey F, Shen CY, Wu PE, Wang HC, Eccles D, Evans DG, Peto J, Fletcher O, Johnson N, Seal S, Stratton MR, Rahman N, Chenevix-Trench G, Bojesen SE, Nordestgaard BG, Axelsson CK, Garcia-Closas M, Brinton L, Chanock S, Lissowska J, Peplonska B, Nevanlinna H, Fagerholm R, Eerola H, Kang D, Yoo KY, Noh DY, Ahn SH, Hunter DJ, Hankinson SE, Cox DG, Hall P, Wedren S, Liu J, Low YL, Bogdanova N, Schürmann P, Dörk T, Tollenaar RA, Jacobi CE, Devilee P, Klijn JG, Sigurdson AJ, Doody MM, Alexander BH, Zhang J, Cox A, Brock IW, MacPherson G, Reed MW, Couch FJ, Goode EL, Olson JE, Meijers-Heijboer H, van den Ouweland A, Uitterlinden A, Rivadeneira F, Milne RL, Ribas G, Gonzalez-Neira A, Benitez J, Hopper JL, McCredie M, Southey M, Giles GG, Schroen C, Justenhoven C, Brauch H, Hamann U, Ko YD, Spurdle AB, Beesley J, Chen X, kConFab, AOCS Management Group, Mannermaa A, Kosma VM, Kataja V, Hartikainen J, Day NE, Cox DR, Ponder BA (2007) Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 447: 1087-1093
6. Eccles DM, Evans DG, Mackay J (2000) Guidelines for a genetic risk based approach to advising women with family history of breast cancer. UK cancer family study group (UKCFSG). J Med Genet 37: 203-209
7. Haites NE, Hodgson SV, the Scottish working group on cancer genetics (2002) Guidelines for development of cancer genetics services. In: CH11 in Familial Breast and Ovarian Cancer: Genetics, Screening and Management, Morrison PJ, Hodgson SV, Haites NE (eds) pp 166-193. Cambridge, Cambridge University Press
8. Hunter DJ, Kraft P, Jacobs KB, Cox DG, Yeager M, Hankinson SE, Wacholder S, Wang Z, Welch R, Hutchinson A, Wang J, Yu K, Chatterjee N, Orr N, Willett WC, Colditz GA, Ziegler RG, Berg CD, Buys SS, McCarty CA, Feigelson HS, Calle EE, Thun MJ, Hayes RB, Tucker M, Gerhard DS, Farumeni JF, Hoover RN, Thomas G, Chanock SJ (2007) A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet 39: 870-874
9. National Institute for Clinical Excellence (NICE) (2004) Familial breast cancer. The classification of women at risk of familial breast cancer in primary, secondary and tertiary care. Clinical Guideline 14. London
10. Nelson HD, Huffman LH, Fu R, Harris EL (2005) Genetic risk assessment and BRCA mutation testing for breast/ovarian cancer susceptibility: systematic evidence review for the US preventive services task force. Ann Intern Med 143: 362-379
11. Public Health Genetics Unit (UK) (1998) Report of consensus meeting on the management of women with a family history of breast cancer. London
12. Scottish Office Home and Health Department (1998) Cancer Genetics services in Scotland: a report by the priority areas cancer team/genetics sub-committee of the Scottish cancer co-ordinating advisory subcommittee. Edinburgh
13. Scottish Intercollegiate guidelines Network (SIGN) Guideline 29 (1998) Breast Cancer in Women. Edinburgh
14. Watson E, Clements A, Austoker J (1999) Familial Breast and Ovarian Cancer - An Information Pack for Primary Care. Oxford: Cancer Research Campaign